BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20462338)

  • 1. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.
    Sredniawa B; Mazurek M; Lenarczyk R; Kowalski O; Kowalczyk J; Kalarus Z
    Future Cardiol; 2010 May; 6(3):315-23. PubMed ID: 20462338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrillator implantation early after myocardial infarction.
    Steinbeck G; Andresen D; Seidl K; Brachmann J; Hoffmann E; Wojciechowski D; Kornacewicz-Jach Z; Sredniawa B; Lupkovics G; Hofgärtner F; Lubinski A; Rosenqvist M; Habets A; Wegscheider K; Senges J;
    N Engl J Med; 2009 Oct; 361(15):1427-36. PubMed ID: 19812399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
    Piccini JP; Al-Khatib SM; Myers ER; Anstrom KJ; Buxton AE; Peterson ED; Sanders GD
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):791-8. PubMed ID: 20132397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trial.
    Ottervanger JP; Ramdat Misier AR; Zijlstra F; Schalij MJ; Wever E; Jordaens LJ; Henriques JP; de Boer MJ; Robbe HW; Wellens HJ;
    Am Heart J; 2006 Oct; 152(4):636-40. PubMed ID: 16996827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule.
    Lim HS; Lip GY; Tse HF
    Europace; 2008 May; 10(5):536-9. PubMed ID: 18367548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate Risk-Stratification Improves Survival (IRIS): study protocol.
    Steinbeck G; Andresen D; Senges J; Hoffmann E; Seidl K; Brachmann J;
    Europace; 2004 Sep; 6(5):392-9. PubMed ID: 15294263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
    Goldberger JJ; Passman R
    J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): rationale, design and specific aims.
    Grönefeld G; Connolly SJ; Hohnloser SH;
    Card Electrophysiol Rev; 2003 Dec; 7(4):447-51. PubMed ID: 15071273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
    Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
    Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary prevention of sudden cardiac death implanted cardioverter defibrillator (ICD) versus antiarrhythmic drugs].
    Iturralde Torres P
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-129-32. PubMed ID: 18938711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines.
    Foley PW; Addison CE; Whinney SB; Patel K; Cunningham D; Frenneaux MP; Leyva F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S131-4. PubMed ID: 19250076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
    Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G
    Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.
    Atary JZ; Borleffs CJ; Liem SS; Bax JJ; van der Hoeven BL; Bootsma M; van der Wall EE; van Erven L; Schalij MJ
    Europace; 2010 Mar; 12(3):378-84. PubMed ID: 20056593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time dependence of mortality risk and defibrillator benefit after myocardial infarction.
    Wilber DJ; Zareba W; Hall WJ; Brown MW; Lin AC; Andrews ML; Burke M; Moss AJ
    Circulation; 2004 Mar; 109(9):1082-4. PubMed ID: 14993128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.